Conditions: Asthma; Moderate AsthmaInterventions: Drug: REGN3500; Drug: PlaceboSponsors: Regeneron Pharmaceuticals; SanofiNot yet recruiting – verified December 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 (Rhizen Pharmaceuticals 3128)
Conditions: Healthy Volunteers; AsthmaInterventions: Drug: RP3128; Drug: PlaceboSponsor: Rhizen Pharmaceuticals SARecruiting – verified November 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
Condition: AsthmaInterventions: Drug: MSTT1041A; Drug: PlaceboSponsor: Hoffmann-La RocheRecruiting – verified September 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Safety of long-acting ?2-agonists in asthma.
Related Articles Safety of long-acting ?2-agonists in asthma. Lancet Respir Med. 2016 Sep 21; Authors: Rishton L PMID: 27665514 [PubMed – as supplied by publisher] View full post on pubmed: asthma
An Open-label Study to Evaluate the Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma
Condition: Inadequately Controlled AsthmaIntervention: Biological: Tralokinumab open-labelSponsor: AstraZenecaNot yet recruiting – verified September 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With Asthma
Condition: AsthmaInterventions: Drug: Indacaterol acetate 75 ?g; Drug: Indacaterol acetate 150 ?gSponsor: Novartis PharmaceuticalsNot yet recruiting – verified August 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Evaluation of Tolerability and Safety of “Allergovac Poliplus” in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice
Conditions: Allergic Rhinitis; Rhinoconjunctivitis; AsthmaIntervention: Biological: Allergovac PoliplusSponsor: BIAL Industrial Farmacéutica S.A.Not yet recruiting – verified July 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days
Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)
Condition: Hypereosinophilic SyndromeInterventions: Drug: Mepolizumab 300 mg; Drug: Placebo matching mepolizumab; Drug: Active OCS capsules (5 mg prednisolone or prednisone); Drug: Placebo matching OCS capsulesSponsor: GlaxoSmithKlineNot yet recruiting – verified July 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14…
Safety First This Summer: Your Child’s Asthma Checklist – Tri County Sentry (blog)
Tri County Sentry (blog) Safety First This Summer: Your Child's Asthma ChecklistTri County Sentry (blog)Breathing easy is hard when you're Black, literally and figuratively. African Americans are 3 times more likely to be hospitalized for asthma than other races. Blacks…